Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALB | P02768 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14577794 | 1.00 | TK1 (0.59) | TK1LMNAALBTSHRBLM | |
| SCHEMBL14421795 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL925743 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL29711774 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL14596607 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL23485 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL762579 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL13286394 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL22992337 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM | |
| SCHEMBL27505365 | 0.86 | LMNA (0.58) | TK1LMNAALBTSHRBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024123-A1 | NOVEL CITICOLINE DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2007083173-A2 | MONONUCLEOTIDES AND MONONUCLEOSIDES FOR USE IN THERAPY | UNIVERSITY OF DEBRECEN (HU) | 2007-07-26 | — | — | WO | claimed |
| WO-1995011685-A1 | 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1995-05-04 | — | — | WO | claimed |
| US-20230037279-A9 | METHOD FOR DIAGNOSING DISEASES USING MULTIPLEX FLUORESCENCE AND SEQUENCING | MultiplexDX, s.r.o. (SK) | 2023-02-02 | — | — | US | disclosed |
| US-20220002812-A1 | METHOD FOR DIAGNOSING DISEASES USING MULTIPLEX FLUORESCENCE AND SEQUENCING | MULTIPLEXDX S R O (SK) | 2022-01-06 | — | — | US | disclosed |
| US-20210254067-A1 | MICRORNA INHIBITORS FOR USE IN TREATING METABOLIC DISEASES | HELMHOLTZ ZENTRUM MUENCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT (GMBH) (DE) | 2021-08-19 | — | — | US | disclosed |
| EP-3850099-A1 | MICRORNA INHIBITORS FOR USE IN TREATING METABOLIC DISEASES | Helmholtz Zentrum München Forschungszentrum für Gesundheit und Umwelt GmbH (DE) | 2021-07-21 | — | — | EP | disclosed |
| EP-3194597-B1 | ALLELE-SPECIFIC THERAPY FOR HUNTINGTON DISEASE HAPLOTYPES | UNIV BRITISH COLUMBIA (CA) | 2021-06-30 | — | — | EP | disclosed |
| EP-3775277-A1 | METHOD FOR DIAGNOSING DISEASES USING MULTIPLEX FLUORESCENCE AND SEQUENCING | MultiplexDX, s.r.o. (SK) | 2021-02-17 | — | — | EP | disclosed |
| US-10731160-B2 | Allele-specific therapy for Huntington disease haplotypes | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-08-04 | — | — | US | disclosed |
| US-20200199595-A1 | ALLELE-SPECIFIC THERAPY FOR HUNTINGTON DISEASE HAPLOTYPES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-06-25 | — | — | US | disclosed |
| WO-2008106803-A1 | DOUBLE-STRANDED LOCKED NUCLEIC ACID COMPOSITIONS | NVENTA BIOPHARMACEUTICALS CORPORATION (US) | 2008-09-12 | — | — | WO | disclosed |
| WO-2007083173-A2 | MONONUCLEOTIDES AND MONONUCLEOSIDES FOR USE IN THERAPY | UNIVERSITY OF DEBRECEN (HU) | 2007-07-26 | — | — | WO | disclosed |
| EP-0974672-B1 | Improved primers for AFLP amplification | KEYGENE NV (NL) | 2003-04-09 | — | — | EP | disclosed |
| US-6107039-A | MIXING SAMPLE OF NUCLEIC ACID SEQUENCE TO BE ANALYZED WITH OLIGONUCLEOTIDE PROBE CONTAINING AT LEAST ONE THIOL-PROTECTED PYRIMIDINE NUCLEOTIDE, EXPOSING TO ENDONUCLEASE, AND IDENTIFYING FRAGMENTS HAVING HYBRIDIZED PROBE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2000-08-22 | — | — | US | disclosed |
| EP-0974672-A1 | Improved primers for AFLP amplification | KEYGENE N.V. (NL) | 2000-01-26 | — | — | EP | disclosed |
| US-6008334-A | MODIFIED PYRIMIDINE NUCLEOSIDES/NUCLEOTIDES WITH PROTECTED THIOL GROUP ATTACHED AT 5 POSITION OF BASE THAT IS NOT INVOLVED IN WATSON-CRICK BASE PARING; FOR USE IN CHEMICAL AND ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1998003532-A9 | BASE-PROTECTED NUCLEOTIDE ANALOGS WITH PROTECTED THIOL GROUPS | — | 1998-05-28 | — | — | WO | disclosed |
| WO-1995011685-A1 | 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1995-05-04 | — | — | WO | disclosed |
| US-4749647-A | Polymerization-induced separation assay using recognition pairs | GENETIC SYSTEMS CORPORATION (US) | 1988-06-07 | — | — | US | disclosed |